Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    CP 690550 citrate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Breckenridge Launches Tofacitinib Tablets, Generic of Xeljanz®
    Breckenridge Launches Tofacitinib Tablets, Generic of Xeljanz®

    04 Jun 2026

    // PRESS RELEASE

    https://towainternational.com/press/breckenridge-announces-launch-of-tofacitinib-tablets-generic-equivalent-of-xeljanz-by-pfizer/

    PRESS RELEASE
    04 Jun 2026
    Share Share
    Hikma Launches Tofacitinib Oral Solution in the US
    Hikma Launches Tofacitinib Oral Solution in the US

    03 Jun 2026

    // PRESS RELEASE

    https://www.hikma.com/news/hikma-launches-tofacitinib-oral-solution-in-the-us/

    PRESS RELEASE
    03 Jun 2026
    Share Share
    Breckenridge’s Generics Tofacitinib Receives Approval in US
    Breckenridge’s Generics Tofacitinib Receives Approval in US

    03 Jun 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209633

    FDA
    03 Jun 2026
    Share Share
    Aurobindo Pharma’s Generics Tofacitinib Receives Approval in US
    Aurobindo Pharma’s Generics Tofacitinib Receives Approval in US

    03 Jun 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215356

    FDA
    03 Jun 2026
    Share Share
    Sun Pharma’ Generics Tofacitinib Citrate Receives Approval in US
    Sun Pharma’ Generics Tofacitinib Citrate Receives Approval in US

    03 Jun 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218407

    FDA
    03 Jun 2026
    Share Share
    Somerset’ Generics Tofacitinib Citrate Receives Approval in US
    Somerset’ Generics Tofacitinib Citrate Receives Approval in US

    03 Jun 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220137

    FDA
    03 Jun 2026
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.